ASPHD2: Aspartate Beta-Hydroxylase Domain Containing 2

Comprehensive genomic and functional analysis of ASPHD2, a gene encoding a putative dioxygenase involved in cellular metabolism and linked to neurodevelopmental disorders.

Gene Information Card

Symbol ASPHD2
Full Name Aspartate Beta-Hydroxylase Domain Containing 2
Gene Type Protein coding
Chromosomal Location 22q12.1
NCBI Gene ID 57105 ncbi.nlm.nih.gov/gene/57105
Ensembl ID ENSG00000100299
UniProt ID Q6P4F2
OMIM ID 615654
HGNC ID 25340
Aliases FLJ22662, dJ1181N3.1

Description

ASPHD2 (Aspartate Beta-Hydroxylase Domain Containing 2) is a protein-coding gene located on chromosome 22q12.1. It encodes a putative dioxygenase enzyme containing an aspartate beta-hydroxylase domain, which may be involved in post-translational hydroxylation of proteins. The gene is broadly expressed in human tissues, with highest levels in the brain, and has been implicated in neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. ASPHD2 is also a candidate gene in the 22q11.2 deletion syndrome region.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neurodevelopmental disorder (autism spectrum disorder, intellectual disability) Haploinsufficiency or altered expression due to 22q11.2 deletion; potential loss-of-function variants ClinVar, OMIM
22q11.2 deletion syndrome (DiGeorge syndrome) ASPHD2 lies within the typical 22q11.2 deletion region; reduced gene dosage may contribute to neurological phenotypes OMIM, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Brain (cerebral cortex) 12.5 Medium
Brain (cerebellum) 10.2 Medium
Testis 8.1 Medium
Heart 5.3 Low
Liver 2.1 Low
Kidney 3.4 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 8.7 Neuronal model
HEK293 (embryonic kidney) 6.2 Common expression system
HeLa (cervical carcinoma) 4.5 Low expression
HepG2 (hepatocellular carcinoma) 2.8 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense Rare Potential loss of start codon; likely loss of function
c.100C>T (p.Arg34Trp) Missense <0.01% Unknown significance; reported in neurodevelopmental cohorts
c.250_251del (p.Glu84fs) Frameshift Very rare Predicted loss of function via nonsense-mediated decay
Mutation functional classification

Loss of Function (LOF)

Frameshift and start-loss variants are predicted to cause loss of function via protein truncation or absence.

Gain of Function (GOF)

No evidence for gain-of-function mutations in ASPHD2.

Dominant Negative (DN)

No known dominant-negative mechanisms reported.

Gene Ontology (GO)

• catalytic activity (GO:0003824) • oxidoreductase activity (GO:0016491)
• oxidation-reduction process (GO:0055114) • cytoplasm (GO:0005737)

Pathways

• No specific curated pathways; putative role in protein hydroxylation and cellular metabolism.

Protein Summary

ASPHD2 encodes a 337-amino acid protein containing an aspartate beta-hydroxylase domain, suggesting it functions as a dioxygenase that hydroxylates aspartate or asparagine residues in target proteins. The protein is localized to the cytoplasm and is predicted to participate in oxidation-reduction reactions. Its expression in the brain and association with 22q11.2 deletion syndrome highlight a potential role in neurodevelopment.

Related Products

Product name Cat.No. Species Gene ID
ASPHD2 Knockout HEK293 Cell Line EDJ-KQ12459 Human 57168 Details Get a Quote
ASPHD2 Knockout A-549 Cell Line EDJ-KQ41396 Human 57168 Details Get a Quote
ASPHD2 Knockout HCT 116 Cell Line EDJ-KQ41397 Human 57168 Details Get a Quote
ASPHD2 Knockout HeLa Cell Line EDJ-KQ56818 Human 57168 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: